Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
31 January 2024 | Story EDZANI NEPHALELA | Photo ANJA AUCAMP
Dr Martin Laubscher
Dr Martin Laubscher’s thesis, crowned with the Andrew Murray-Desmond Tutu Prize, is testament to the university’s unwavering commitment to scholarly excellence.

In a historic triumph that reverberates over four decades since its inception, the UFS has clinched the coveted Andrew Murray Prize – now renamed the Andrew Murray-Desmond Tutu Prize – for the first time. Standing shoulder to shoulder with institutions such as the University of Pretoria (UP) and Stellenbosch University (SU), this achievement marks a significant milestone in the UFS’ journey.

At the heart of this accomplishment lies the profound contribution of Dr Martin Laubscher, distinguished Senior Lecturer specialising in Practical and Missional Theology in the Faculty of Theology and Religion. Dr Laubscher’s dedication and scholarly prowess culminated in the groundbreaking work titled Publieke teologie as profetiese teologie? (Public theology as prophetic theology), a revised edition of his doctoral thesis, which was originally crafted at Stellenbosch University in 2020, with a focus on the eminent Karl Barth.

Dr Laubscher received the Andrew Murray Prize for Theological Books in Afrikaans for his research and insightful analysis. The journey started when he realised, under the guidance of his study leader, Prof Dion Forster, that his script had the potential to be published in Afrikaans. Sun Media’s interest in publishing this work in Afrikaans, led to it being the first-ever published thesis in Afrikaans. Dr Laubscher recalls, “I was grateful and excited about Sun Media’s interest. The book emerged within a year, and during a celebratory launch Prof Forster suggested I submit it for the Andrew Murray Prize.”

Earlier this year, Dr Laubscher was excited to learn that he was being shortlisted for the prestigious award. Reflecting on the significant moment, he shares, “The elation I felt upon receiving the news was unparalleled. I was not only celebrating a personal triumph, but also etching my name as the first laureate from our faculty to secure this prestigious accolade.”

News Archive

Medical student stars in local movie
2015-10-15


Sung-Hoon as the on-screen character Operator 2

Sung-Hoon Kim’s dream of starring in a movie became a reality with the release of Reconnect on 16 October 2015 in Nu Metro cinemas across the country.

The second-year medical student at the University of the Free State transitioned into a professional actor in December 2013, when he made the leap from his high school drama stage to shooting for the big screen.

“I did plays in high school where I had roles like Simba in The Lion King,” said the first-time movie star. 

The film is a purely South African creation. It is set in Potchefstroom and Klerksdorp, Sung-Hoon’s former and current hometowns. Sung-Hoon plays two major roles: XJ-1- a robot, and the on-screen role of artificial intelligence Operator 2 at SKY CORP - an international intelligence company that protects top secret information from around the world.

Reconnect was directed by the late Marius Swanepoel, who Sung-Hoon described as “a great blessing to all those privileged enough to have known him.” The movie explores the relationship between human beings and artificial intelligence.

Eric Scott discovers XJ-1 at an abandoned warehouse, and transfers him to SKY CORP where he becomes destructive. Eric and his friend, Jason, are then faced with the challenge of containing the situation, and saving the company which XJ-1 has infected with a dangerous virus. As the science-fiction action unfolds, viewers catch a glimpse into the life of XJ-1.

Shooting the movie was an exciting experience for Sung-Hoon. “It was quite fun because I like imitating voices,” he said.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept